Cargando…

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery

PURPOSE: By examining and identifying circulating tumor cell (CTC) counts and subtypes of peripheral blood in osteosarcoma patients, we evaluated the relationship between CTCs and characteristics of osteosarcoma patients, as well as CTC changes after neoadjuvant chemotherapy and surgery. METHODS: Ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhen-Jie, Tan, Jia-Chang, Qin, Xiong, Liu, Bin, Yuan, Zhen-Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138968/ https://www.ncbi.nlm.nih.gov/pubmed/30237736 http://dx.doi.org/10.2147/CMAR.S176515

Ejemplares similares

Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma
por: Li, Minghui, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy and Expandable Prosthesis Reconstruction to Treat Osteosarcoma around the Knee in Children
por: Huang, Junqi, et al.
Publicado: (2022)

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
por: Robl, Bernhard, et al.
Publicado: (2015)

Bone transport using the Ilizarov method for osteosarcoma patients with tumor resection and neoadjuvant chemotherapy
por: Wang, Wei, et al.
Publicado: (2019)

Conventional osteosarcoma of the mandible successfully treated with radical surgery and adjuvant chemotherapy after responding poorly to neoadjuvant chemotherapy: a case report
por: Kimura, Yutaro, et al.
Publicado: (2017)

Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma
por: Yu, Hong, et al.
Publicado: (2023)

Transition from Tumor Tissue to Bone Marrow in Patients with Appendicular Osteosarcoma after Neoadjuvant Chemotherapy
por: Deng, Zhi-Ping, et al.
Publicado: (2017)

A meta‐analysis comparing efficiency of limb‐salvage surgery vs amputation on patients with osteosarcoma treated with neoadjuvant chemotherapy
por: Abdelgawad, Mohamed A, et al.
Publicado: (2022)

Therapeutic effect of neoadjuvant chemotherapy combined with curettage to treat distal femoral osteosarcoma: A case report
por: Lai, Qi, et al.
Publicado: (2017)

The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma
por: Zhong, Guang-Xian, et al.
Publicado: (2017)

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer
por: Kaigorodova, Evgeniya V., et al.
Publicado: (2018)

Efficacy of Neoadjuvant Chemotherapy plus Limb-Sparing Surgery for Osteosarcoma and Its Impact on Long-Term Quality of Life
por: Jing, Shixia, et al.
Publicado: (2022)

Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study
por: Tang, Haijun, et al.
Publicado: (2022)

Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma
por: Erdoğan, Furkan, et al.
Publicado: (2023)

Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
por: Ni, Chao, et al.
Publicado: (2020)

Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy
por: Chang, Ji Hyun, et al.
Publicado: (2016)

Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study
por: Yuan, Guangke, et al.
Publicado: (2017)

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
por: Chalopin, Antoine, et al.
Publicado: (2018)

Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes
por: Xu, Ming, et al.
Publicado: (2014)

Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy
por: LI, LI, et al.
Publicado: (2013)

The prognostic role of a phospho-Stathmin 1 signature in breast cancer treated with neoadjuvant chemotherapy
por: Xie, Zhen, et al.
Publicado: (2022)

Marrow signal mimicking tumor on MRI T1-weighted imaging after neoadjuvant chemotherapy in extremity osteosarcomas
por: Deng, Zhiping, et al.
Publicado: (2016)

Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy
por: Heishima, Kazuki, et al.
Publicado: (2019)

FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer
por: Xie, Qin, et al.
Publicado: (2020)

The association of XPG and MMS19L polymorphisms response to chemotherapy in osteosarcoma
por: Zhao, Yi-lei, et al.
Publicado: (2013)

“No Ink on Tumor” in Breast-Conserving Surgery after Neoadjuvant Chemotherapy
por: Atzori, Giulia, et al.
Publicado: (2022)

Dynamic alteration and prognostic significance of tumor‐associated CD68(+) and CD68(+)PD‐L1(−) macrophages in muscle‐invasive bladder cancer treated with neoadjuvant chemotherapy
por: Wu, Jie, et al.
Publicado: (2022)

Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
por: Talamantes, Sarah, et al.
Publicado: (2020)

Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma
por: Li, Zhendong, et al.
Publicado: (2022)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)

Predictive value of DCE-MRI and IVIM-DWI in osteosarcoma patients with neoadjuvant chemotherapy
por: Xia, Xibin, et al.
Publicado: (2022)

Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
por: Jakabova, Anna, et al.
Publicado: (2021)

The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors
por: Wang, Yujie, et al.
Publicado: (2022)

Predictive role of Glutathione S-transferases (GSTs) on the prognosis of osteosarcoma patients treated with chemotherapy
por: Teng, Jia-wen, et al.
Publicado: (2013)

Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer
por: Li, Yang, et al.
Publicado: (2018)

The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery
por: Yang, Shi‐Ping, et al.
Publicado: (2022)

Survival analysis of children with stage II testicular malignant germ cell tumors treated with surgery or surgery combined with adjuvant chemotherapy
por: Lu, Su-Ying, et al.
Publicado: (2015)

Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer
por: Huang, Miao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r03njlig0b1c9b36m9np4jp6ch